title: Highlights on novel imaging methods of pancreatic cancer.
abstract: Pancreatic cancer is the fourth leading cause of cancer deaths. Since the majority of patients present with incurable metastatic disease, novel imaging methods are needed to identify pancreatic cancer and assess response to therapy. Research presented at the 2013 American Society of Oncology (ASCO) Annual Meeting provided insight into potential imaging methods. We discuss Abstracts #4049, #TPS4144, #TPS4146, and #E15069 in this paper.
authors.affiliation: Department of Radiology, Columbia University. New York, NY 10032, USA. sk3552@columbia.edu
authors.forename: Saravanan Kokila
authors.initials: SK
authors.lastname: Krishnamoorthy
authors.forename: Morris
authors.initials: M
authors.lastname: Hayim
authors.forename: Tyler
authors.initials: T
authors.lastname: Vestal
authors.forename: Muhammad Wasif
authors.initials: MW
authors.lastname: Saif
mesh_terms: D003952:Diagnostic Imaging / Q000379:methods*; D006801:Humans; D008279:Magnetic Resonance Imaging; D010190:Pancreatic Neoplasms / Q000175:diagnosis* / Q000188:drug therapy*; D049268:Positron-Emission Tomography; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity